CNTA Stock Analysis: Buy, Sell, or Hold?
CNTA - Centessa Pharmaceuticals plc American Depositary Shares
$40.50
0.32 (0.80%)
▲
5d:
+1.86%
30d:
+1.73%
90d:
+56.13%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNTA is currently trading at $40.50, which is considered extended relative to its 30-day fair value range of $39.65 to $40.04.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$39.65 -
$40.04
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($44.17)
Trading Range Analysis
30-Day Trading Range
$39.65 -
$40.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$39.58
Resistance Level
$40.56
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.64
Wall Street Target
$44.17
(+9.1%)
Share & Embed Analysis
Last updated: July 04, 2026 12:40 AM ET
Data refreshes hourly during market hours. Next update: 1:40 AM
Data refreshes hourly during market hours. Next update: 1:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen M Anderson
SELL
41076 shares
2026-03-26
Karen M Anderson
SELL
10043 shares
2026-03-17
Karen M Anderson
SELL
64768 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
